Psychiatry · Flowchart
ADHD (attention deficit hyperactivity disorder)
FreeCause to treatmentHY high-yield
ADHD from cause to treatment: genes and early-life risks, frontostriatal dopamine and norepinephrine, inattention and hyperactivity, DSM-5 criteria in two settings, what to rule out, comorbidities, behaviour therapy, stimulants and non-stimulants.
Updated
Whole chart as designed

Read this flowchart as text
The same content as the chart above, step by step. Points marked high-yield are the ones most often tested.
1. Cause
- Genes: Highly heritable (about 70–80%); runs in families
- Early-life risks: Prematurity, low birth weight, prenatal alcohol or tobacco, lead
2. Pathogenesis
- Frontostriatal circuits work differently: Lower dopamine and norepinephrine signalling → weaker attention control and inhibition
3. Clinical features
- Inattention: Careless mistakes, does not listen, loses things, forgetful, easily distracted
- Hyperactivity and impulsivity: Fidgets, leaves seat, talks too much, interrupts, cannot wait
- DSM-5 criteria: 6 or more symptoms (5 from age 17) for 6 months, some before age 12, in 2 or more settings, impairing function (high-yield)
4. Diagnosis
- Clinical diagnosis: Rating scales from parents and teachers; no lab or imaging test
- Rule out: Hearing or vision loss, learning disorder, anxiety, depression, sleep problems, thyroid disease, absence seizures, abuse (high-yield)
5. Comorbidities
- Often comes with: Oppositional defiant and conduct disorder, learning disorders, anxiety, tics; later substance use and injuries
6. Treatment
- Preschool (4–5 years): Parent training in behaviour management first; methylphenidate if not enough
- Age 6 and older: Stimulants (methylphenidate, amphetamines) plus behavioural therapy and school support (high-yield)
- Non-stimulants: Atomoxetine, guanfacine, clonidine: for tics, misuse risk or side effects
- Stimulant side effects: Poor appetite, weight loss, insomnia, raised heart rate and blood pressure